Hepatocellular carcinoma (HCC) is one of the most common types of cancers and a global
health challenge with a low early diagnosis rate and high mortality. The coagulation …

Abstract Phosphoinositide-3-Kinase Regulatory Subunit 1 (PIK3R1) is believed to function
as a tumor suppressor, while Phosphoinositide-3-Kinase Regulatory Subunit 2 (PIK3R2) as …

Cancer cells integrate multiple biosynthetic demands to drive unrestricted proliferation. How
these cellular processes crosstalk to fuel cancer cell growth is still not fully understood. Here …

The liver is the primary organ regulating glucose metabolism. In our recent study, cinnamon
improved liver function in diabetic mice. However, it is not clear whether cinnamon can …

Isoniazid (INH) is a first-line anti-tuberculosis drug used for nearly 70 years. However, the
mechanism underlying the side effects of INH has remained elusive. Here, we report that …

Background Increasing evidence has suggested that microRNAs (miRNAs) act as key post-
transcriptional regulators in tumor progression. Previous studies have confirmed that miR-17 …

Dandelion polysaccharides (DP) have been reported to possess anticancer activity. In this
study, we showed that DP significantly inhibited Hepatocellular carcinoma (HCC) cell …

Background: Increasing circular RNAs (circRNAs) are reported to participate in cancer
progression. Nonetheless, the role of circRNAs in nasopharyngeal carcinoma (NPC) has not …

The combination of a PD-L1 inhibitor and an anti-angiogenic agent has become the new
reference standard in the first-line treatment of non-excisable hepatocellular carcinoma …

Purpose. The morbidity and fatality rates of non‐small‐cell lung cancer (NSCLC) were high,
although a combination of multiple treatments was used. Fisetin, a small flavonoid …